Literature DB >> 21885973

Inclusion body myositis.

Steven A Greenberg1.   

Abstract

PURPOSE OF REVIEW: Sporadic inclusion body myositis (sIBM) is a poorly understood immune and degenerative disease of skeletal muscle. Here, current opinion of the nature of this disease is summarized. RECENT
FINDINGS: Recent findings for sIBM include further characterization of muscle involvement through magnetic resonance imaging, the role of muscle as a host for immune cells, progress in the role of extranuclear TDP-43 in causing cellular injury, and the discovery of a new sIBM autoantibody.
SUMMARY: sIBM understanding continues to advance, with progress regarding the mechanism of this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21885973     DOI: 10.1097/BOR.0b013e32834b53cc

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

Review 1.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

Review 2.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

Review 3.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

4.  Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43).

Authors:  Maurizio Romano; Emanuele Buratti; Giulia Romano; Raffaella Klima; Lisa Del Bel Belluz; Cristiana Stuani; Francisco Baralle; Fabian Feiguin
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

Review 5.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

6.  Targeting protein homeostasis in sporadic inclusion body myositis.

Authors:  Mhoriam Ahmed; Pedro M Machado; Adrian Miller; Charlotte Spicer; Laura Herbelin; Jianghua He; Janelle Noel; Yunxia Wang; April L McVey; Mamatha Pasnoor; Philip Gallagher; Jeffrey Statland; Ching-Hua Lu; Bernadett Kalmar; Stefen Brady; Huma Sethi; George Samandouras; Matt Parton; Janice L Holton; Anne Weston; Lucy Collinson; J Paul Taylor; Giampietro Schiavo; Michael G Hanna; Richard J Barohn; Mazen M Dimachkie; Linda Greensmith
Journal:  Sci Transl Med       Date:  2016-03-23       Impact factor: 17.956

7.  T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.

Authors:  Annie Hiniker; Brianne H Daniels; Marta Margeta
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-03       Impact factor: 3.685

8.  Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.

Authors:  Annie Hiniker; Brianne H Daniels; Han S Lee; Marta Margeta
Journal:  Acta Neuropathol Commun       Date:  2013-07-01       Impact factor: 7.801

9.  Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation.

Authors:  Sachiko Homma; Mary Lou Beermann; Frederick M Boyce; Jeffrey Boone Miller
Journal:  Ann Clin Transl Neurol       Date:  2015-01-15       Impact factor: 4.511

10.  Hypokalemia-Induced Rhabdomyolysis by Primary Aldosteronism Coexistent With Sporadic Inclusion Body Myositis.

Authors:  Jong Ha Lee; Eunkuk Kim; Suk Chon
Journal:  Ann Rehabil Med       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.